corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 13335

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: news

Taylor L.
EU drug info proposals 'driven by industry interests'
Pharma Times 2008 Mar 27
http://www.pharmatimes.com/WorldNews/article.aspx?id=13143&src=EWorldNews


Full text:

The European Commission’s proposal to amend the rules covering drug information provided by the industry to patients is “clearly driven by the pharmaceutical industry’s interests, not by the interests of patients,” claims leading UK patient advocacy group The Picker Institute.

The proposal’s “exclusive focus on allowing pharmaceutical companies to provide direct to patient/public information conflicts with the Commission’s stated intention,” which is that patients’ interests must come first, it adds.

The Picker Institute’s comments appear in its response to the Commission’s public consultation on its plan for a legal proposal on information to patients, which seeks to ensure “good-quality, objective, reliable and non-promotional information on prescription-only medicinal products” and harmonise its provision throughout the European Union. Currently, access to such information is very unequal among the member states, says the consultation document.

As well as putting the interests of patients first, the Commission says its proposal would retain the role of health care professionals as the primary source of health information and maintain the current ban on direct-to-consumer (DTC) advertising of prescription medicines. It would ensure a clear distinction between advertising and non-promotional information, proposing that: “basically, communication not covered by the definition of advertisement should be regarded as information.” This distinction would create a framework for the industry to provide “certain information on their medicines,” enabling patients and the public to obtain “objective information from reliable sources,” it says.

The Picker Institute’s response acknowledges the current problems of unequal access and says it would “wholeheartedly support genuinely patient-focused initiatives to ensure equality in the provision of, and access to, information.” However, it claims that the proposal seeks “to allow pharmaceutical companies to provide direct-to-consumer information about prescription-only medicines,” and urges the Commission to reconsider it.

Moreover, the initiative depends on there being a workable distinction between “advertising” and “information,” but no groundwork has been done to develop this, says the Institute; without it, the distinction will be unworkable in practice and the proposal would have the effect of undermining the ban on DTC advertising, it adds.

Nor does the proposal reflect the evidence base regarding patients’ information needs, which shows that the most significant unmet need is for comparative and comparable information to enable them to make informed decisions on the most appropriate treatment. The “DTC information” which could be provided to consumers under the proposal would not enable them to compare different products, and this “clearly demonstrates that the pharmaceutical industry’s interests are the priority, not patients’ interests,” says the Institute. Patients should be able to make rational decisions, but advertising does not support this, it adds.

The Commission’s Directorate-General for Enterprise and Industry is calling for responses to the consultation from all interested parties, to be received by April 7.

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








Far too large a section of the treatment of disease is to-day controlled by the big manufacturing pharmacists, who have enslaved us in a plausible pseudo-science...
The blind faith which some men have in medicines illustrates too often the greatest of all human capacities - the capacity for self deception...
Some one will say, Is this all your science has to tell us? Is this the outcome of decades of good clinical work, of patient study of the disease, of anxious trial in such good faith of so many drugs? Give us back the childlike trust of the fathers in antimony and in the lancet rather than this cold nihilism. Not at all! Let us accept the truth, however unpleasant it may be, and with the death rate staring us in the face, let us not be deceived with vain fancies...
we need a stern, iconoclastic spirit which leads, not to nihilism, but to an active skepticism - not the passive skepticism, born of despair, but the active skepticism born of a knowledge that recognizes its limitations and knows full well that only in this attitude of mind can true progress be made.
- William Osler 1909